home All News open_in_new Full Article

Bayer winkt für Augenmittel Eylea Zulassung in EU für längere Behandlung

Pharma - Der Pharma- und Agrarchemiekonzern Bayer kann sich Hoffnungen auf eine Zulassung seines Kassenschlagers Eylea für eine längere Behandlung in der EU machen.


today 2 w. ago attach_file Other

attach_file Other
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Transport
attach_file Other
attach_file Other


ID: 4129930755
Add Watch Country

arrow_drop_down